Cardiogen (AEDR Peptide)

Cardiogen is an experimental short-chain peptide associated with cardiac and cardiovascular tissue research. It is commonly described as a tetrapeptide with the sequence Ala-Glu-Asp-Arg (AEDR).

In experimental research, Cardiogen is investigated in connection with cardiomyocyte biology, cardiac tissue homeostasis, cellular metabolism, cell survival, and tissue-specific regulatory mechanisms, providing a research tool for studying cellular and molecular responses in cardiac tissue.

Research has also explored potential relationships between Cardiogen and cellular energy metabolism, mitochondrial function, gene expression, and intracellular signaling pathways, making it of interest in studies of cardiomyocyte function and cardiovascular tissue biology.

As a short-chain bioregulatory peptide, Cardiogen may also serve as an experimental tool for investigating relationships between peptide signaling, tissue homeostasis, cellular stress responses, and cardiac tissue remodeling.

Evidence involving Cardiogen remains limited, particularly with respect to large-scale human clinical studies. Experimental findings should therefore not be interpreted as established cardioprotective effects, improvements in cardiac function, or treatments for cardiovascular disease.

Livraison standard offerte dès 50 $ vers les États-Unis, le Canada, le Mexique et l'Europe. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.